March 27, 2017 12:45 AM ET

Life Sciences Tools and Services

Company Overview of WaferGen Bio-systems, Inc.

Company Overview

WaferGen Bio-systems, Inc. develops, manufactures, and sells systems for single-cell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. It offers SmartChip Real-Time polymerase chain reaction (PCR) system, which provides a suite of gene expression and genome analysis technologies enabling biomarker discovery and validation on a single platform with the sensitivity and accuracy of PCR. The company’s SmartChip Real-Time PCR system consists of two instrumentation components comprising a SmartChip MultiSample NanoDispenser for applying sample, assay, and reaction mix to the SmartChip Panels; and a SmartChip Cycler for thermal cycling and collecting data fr...

7400 Paseo Padre Parkway

Fremont, CA 94555

United States

Founded in 2002

55 Employees

Phone:

510-651-4450

Key Executives for WaferGen Bio-systems, Inc.

President and Director
Secretary, Treasurer and Director
Compensation as of Fiscal Year 2016.

WaferGen Bio-systems, Inc. Key Developments

Wafergen Bio-Systems Files Form 15

Wafergen Bio-Systems, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock, $0.001 par value under the Securities Exchange Act of 1934, as amended.

WaferGen Bio-Systems, Inc. Announces Executive Changes

WaferGen Bio-systems, Inc. announced that in connection with the consummation of the Merger and in accordance with the Merger Agreement, each of the then-current directors of the Company resigned from their positions as directors of the Company effective as of the Effective Time. These resignations were not a result of any disagreement between the Company and the directors on any matter relating to the Company's operations, policies or practices. Pursuant to the Merger Agreement, at the Effective Time, Carol Lou, Frank Raab, Kazuki Yamamoto, Shuichiro Matsuzaki and Junichi Mineno became the directors of the Company. In addition, effective as of the Effective Time, all of the executive officers of the Company were removed from their respective positions as executive officers, and Carol Lou became the President of the Company and Frank Raab became the Secretary and Treasurer of the Company.

WaferGen Bio-systems Intends To File With SEC A Certification On Form 15

On February 28, 2017, WaferGen Bio-systems, Inc. (Company) notified the NASDAQ Stock Market LLC (NASDAQ) of the consummation of the Merger and requested that NASDAQ halt trading of the Common Stock effective prior to market open on March 1, 2017 and suspend trading of the Common Stock effective prior to market open on March 2, 2017 and file with the SEC a Form 25 Notification of Removal from Listing and/or Registration to delist and deregister the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (Exchange Act). The Company intends to file with the SEC a certification on Form 15 under the Exchange Act, requesting the suspension of the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act with respect to the Common Stock.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 13, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact WaferGen Bio-systems, Inc., please visit www.wafergen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.